AeroLeads people directory · profile

Matt Jenkins Email & Phone Number

Partner at QHP Capital | Healthcare Private Equity at QHP Capital
Location: Raleigh, North Carolina, United States 18 work roles 2 schools
1 work email found @novaquest.com 3 phones found area 919 and 312 LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email j****@novaquest.com
Direct phone (919) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Partner at QHP Capital | Healthcare Private Equity
Location
Raleigh, North Carolina, United States

Who is Matt Jenkins? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Matt Jenkins is listed as Partner at QHP Capital | Healthcare Private Equity at QHP Capital, based in Raleigh, North Carolina, United States. AeroLeads shows a work email signal at novaquest.com, phone signal with area code 919, 312, and a matched LinkedIn profile for Matt Jenkins.

Matt Jenkins previously worked as Partner at Qhp Capital and Board Member at Univo Irb. Matt Jenkins holds B.S., Business Administration from University Of North Carolina At Chapel Hill.

Company email context

Email format at QHP Capital

This section adds company-level context without repeating Matt Jenkins's masked contact details.

{last}{first_initial}@novaquest.com
86% confidence

AeroLeads found 1 current-domain work email signal for Matt Jenkins. Compare company email patterns before reaching out.

Profile bio

About Matt Jenkins

Matt is currently a Partner with QHP Capital where he is responsible for investment origination and execution, portfolio company monitoring and value creation initiatives, investment policy, and investor relations. Prior to joining QHP Capital, Mr. Jenkins established and led the private equity investment portfolio at RTI International where he focused on precision medicine, clinical research, real world evidence, genomics, pharma services, population healthcare, and consumer-oriented diagnostics. Matt led and managed RTI’s investments including BioIQ (exited), PierianDx (exited), Seven Bridges Genomics (exited), Clinical Ink (exited), and SPH Analytics (exited). Matt has extensive healthcare and biopharma M&A, transaction, and strategic leadership experience having established and led the corporate development functions at RTI International (annual revenues $1.2 billion+) and M*Modal-Medquist a healthcare technology firm acquired by 3M. He previously was a Corporate Vice President at Allscripts-Misys, a public digital healthcare technology organization serving providers, payers, and biopharma clients with annual revenues exceeding $1.4 billion where Matt led corporate development (M&A) and held executive roles in strategic planning, marketing, and business development.Prior to Allscripts, Mr. Jenkins was one of the three founding members of Cellective Therapeutics (acquired by Medimmune) and also worked at one of the most active venture capital firms in the Southeast where he focused on technology and life science equity investments.Matt began his career at Ernst & Young, where he helped grow the Washington, DC practice by leading and delivering performance improvement and strategic advisory engagements for technology sector clients.

Listed skills include Strategic Partnerships, Mergers And Acquisitions, Business Development, Strategic Planning, and 42 others.

Current workplace

Matt Jenkins's current company

Company context helps verify the profile and gives searchers a useful next step.

QHP Capital
Qhp Capital
Partner at QHP Capital | Healthcare Private Equity
AeroLeads page
18 roles · 29 years

Matt Jenkins work experience

A career timeline built from the work history available for this profile.

Partner

Current

Raleigh, North Carolina, Us

Based in the Research Triangle Park of North Carolina, QHP Capital invests in life sciences and pharma services companies with proven products, services, and enabling technologies, utilizing a strategic platform to source, diligence, and create value. Led by a senior team of investment, healthcare, and research professionals, QHP looks to partner with founders and management teams to create long-term value.

Apr 2022 - Present

Board Member

Current

Raleigh, North Carolina, Us

Univo IRB is your next generation independent review board (IRB) specializing in ethical review of Phase I-IV pharmaceutical, device, biologic, behavioral, and psycho-social research.

Oct 2023 - Present

Board Member

Current

Milpitas, Ca, Us

As a leading cell and gene therapy CRO/CDMO, Applied StemCell is a supporter of gene editing and stem cell therapy development. With two high-impact platforms, CRISPR/TARGATT™ Genome Editing and iPSC (GMP grade), we seek to help advance the development of novel therapeutics.

Oct 2023 - Present

Board Member

Current

Raleigh, North Carolina, Us

AutoCruitment offers an online patient screening platform intended to recruit qualified patients for clinical trials and research studies. The company's platform offers algorithms and business logic to transform the time-consuming task of recruiting quality volunteers to participate in clinical trials, enabling clients to increase patient acquisition for specialty procedures and clinical trials in all therapeutic areas. For more information, please visit www.autocruitment.com.

Oct 2022 - Present

Board Member

Current

Winston-Salem, Nc, Us

Clinical ink is the global life science company that brings data, technology, and patient science together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.

Dec 2022 - Present

Board Member

Current

Durham, North Carolina, Us

Lexitas is a full-service ophthalmic biopharmaceutical solutions company focused on providing end-to-end eyecare support and exceptional service to biopharma and medical device clients globally. For more information, please visit www.lexitas.com.

Jun 2022 - Present

Head Of Corporate Development & Private Equity Investments

Research Triangle Park, Nc, Us

Established and led team responsible for executing global inorganic growth. Oversee all merger, acquisition, and investment evaluation and execution. Established and managed portfolio of private equity investments.

Feb 2015 - Apr 2022

Board Observer & Investor

Boston, Massachusetts, Us

Aug 2021 - Mar 2022

Board Observer & Investor

Atlanta, Ga, Us

Nov 2019 - Mar 2022

Board Observer & Investor

Creve Coeur, Missouri, Us

Apr 2018 - Mar 2022

Board Observer & Investor

Winston-Salem, Nc, Us

May 2018 - Nov 2020

Senior Vice President, Strategy & Corporate Development

Franklin, Tn, Us

Established and lead the corporate strategy and M&A functions of a $400m+ global healthcare information technology and services company.

Nov 2011 - Feb 2015

Vp, Corporate Development

Chicago, Il, Us

Feb 2005 - Nov 2011

Co-Founder - Director Finance

Cellective Therapeutics (Acquired By Medimmune)
2003 - 2005 ~2 yrs

Consultant

Cgi

Montreal, Quebec, Ca

Formerly American Management Systems (AMS)

Jan 1997 - Jul 1998
2 education records

Matt Jenkins education

B.S., Business Administration

University Of North Carolina At Chapel Hill

Mba, Finance

Unc Kenan-Flagler Business School
FAQ

Frequently asked questions about Matt Jenkins

Quick answers generated from the profile data available on this page.

What company does Matt Jenkins work for?

Matt Jenkins works for QHP Capital.

What is Matt Jenkins's role at QHP Capital?

Matt Jenkins is listed as Partner at QHP Capital | Healthcare Private Equity at QHP Capital.

What is Matt Jenkins's email address?

AeroLeads has found 1 work email signal at @novaquest.com for Matt Jenkins at QHP Capital.

What is Matt Jenkins's phone number?

AeroLeads has found 3 phone signal(s) with area code 919, 312 for Matt Jenkins at QHP Capital.

Where is Matt Jenkins based?

Matt Jenkins is based in Raleigh, North Carolina, United States while working with QHP Capital.

What companies has Matt Jenkins worked for?

Matt Jenkins has worked for Qhp Capital, Univo Irb, Applied Stemcell, Autocruitment, and Clinical Ink.

How can I contact Matt Jenkins?

You can use AeroLeads to view verified contact signals for Matt Jenkins at QHP Capital, including work email, phone, and LinkedIn data when available.

What schools did Matt Jenkins attend?

Matt Jenkins holds B.S., Business Administration from University Of North Carolina At Chapel Hill.

What skills is Matt Jenkins known for?

Matt Jenkins is listed with skills including Strategic Partnerships, Mergers And Acquisitions, Business Development, Strategic Planning, Strategy, Corporate Development, Business Strategy, and Leadership.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.